SynOx Therapeutics
SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is ...
SynOx Therapeutics's Basic Information
Headquarters
Dublin, Ireland
Founded Year
2020
SynOx Therapeutics's Competitors
Harness Biotechnology
Enzybel Group
IM-RAC Filter Systems
mAbxience
Madrid, Spain
Algorics
Framingham, Massachusetts, United States
Employee Insights
Employee Function
Employee Location
SynOx Therapeutics's Top Employees
Axel Mescheder M.D.
Chief Medical Officer
Raymond Barlow
Chief Executive Officer
Sander Veltkamp
Vice President Clinical Development & Regulatory Affairs
Sarah Clare
Director Of Finance And Operations
Find Your Next Customer with Better Data
Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.
⭐Top-ranked on G2 Crowd
🛡️GDPR compliant•Cancel anytime
✨Free credits every month!
Frequently Asked Questions Regarding SynOx Therapeutics
Where is SynOx Therapeutics's headquarter located?
SynOx Therapeutics's headquarter are located at Ireland.
What is SynOx Therapeutics's official website?
SynOx Therapeutics's official website is https://synoxtherapeutics.com/
What does SynOx Therapeutics do?
SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is ...
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
